cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.15128529
title: Additional file 22 of A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration

description: Addtional file 22. The raw data 2 of QRT-PCR results by setting GAPDH as an internal control.
DOI: 10.6084/m9.figshare.15128529.v1
title: Additional file 22 of A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration

description: Addtional file 22. The raw data 2 of QRT-PCR results by setting GAPDH as an internal control.
DOI: 10.5517/ccdc.csd.cc2d6c00
title: CCDC 2210641: Experimental Crystal Structure Determination

description: Related Article: Wensheng Liu, Yao Huang, Chenhui Ji, Craig A. Grimes, Zerong Liang, Hairong Hu, Qing Kang, Hai-long Yan, Qing-Yun Cai, Yi-Ge Zhou|2024|ACS Sensors|9|759|doi:10.1021/acssensors.3c02069
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.6084/m9.figshare.6739928
title: MOESM1 of Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells

description: Additional file 1: Table S1. Phosphoproteomics data for peptides with large fold-changes at the 1- and 15- minute time points. Table S2. Shared proteins identified in the current study, CXCR4-HIV signaling, and the HIV-1 human protein interaction database. Table S3. Bioinformatic analysis of REACTOME pathways enriched for HIV-responsive phosphoproteins. Table S4. Cluster pathway enrichment analysis of HIV-responsive phosphoproteins. Table S5. Effects of kinase inhibitors on HIV-1 fusion, infection, and post-entry efficiency in primary CD4+ T cells.Table S6. Unprocessed proteomics data. Table S7. Phosphoproteomics data filtered by coefficient of variation (CV). Table S8. Phosphoproteomics data processed for false discovery rate (FDR) calculations. Table S9. Kinase-substrate enrichment analysis (KSEA) scores from phosphoproteomics data. Table S10. Dataset used for kinase-substrate enrichment analysis (KSEA) analysis.
DOI: 10.6084/m9.figshare.6739928.v1
title: MOESM1 of Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells

description: Additional file 1: Table S1. Phosphoproteomics data for peptides with large fold-changes at the 1- and 15- minute time points. Table S2. Shared proteins identified in the current study, CXCR4-HIV signaling, and the HIV-1 human protein interaction database. Table S3. Bioinformatic analysis of REACTOME pathways enriched for HIV-responsive phosphoproteins. Table S4. Cluster pathway enrichment analysis of HIV-responsive phosphoproteins. Table S5. Effects of kinase inhibitors on HIV-1 fusion, infection, and post-entry efficiency in primary CD4+ T cells.Table S6. Unprocessed proteomics data. Table S7. Phosphoproteomics data filtered by coefficient of variation (CV). Table S8. Phosphoproteomics data processed for false discovery rate (FDR) calculations. Table S9. Kinase-substrate enrichment analysis (KSEA) scores from phosphoproteomics data. Table S10. Dataset used for kinase-substrate enrichment analysis (KSEA) analysis.
DOI: 10.6084/m9.figshare.6739931
title: Additional file 2 of Limitations of alignment-free tools in total RNA-seq quantification

description: Zip file containing several data tables in tab-separated format, as well as a readme file that explains the contents of each data file. (ZIP 5 kb)
DOI: 10.6084/m9.figshare.6739931.v1
title: Additional file 2 of Limitations of alignment-free tools in total RNA-seq quantification

description: Zip file containing several data tables in tab-separated format, as well as a readme file that explains the contents of each data file. (ZIP 5 kb)
DOI: 10.5281/zenodo.10141824
title: The IASI/Metop pyrogenic HONO product v2

description: This dataset comprises the version 2 of the pyrogenic HONO product retrieved from IASI/Metop-A (Oct 2007 - Sept 2021), IASI/Metop-B (March 2013 - Sept 2023), and IASI/Metop-C (Sept 2019 - Sept 2023) using the Artificial Neural Network for IASI (ANNI) version 4 retrieval scheme. Each day with successful pyrogenic HONO detections is represented by a .nc file per instrument. For detailed information on the HONO product, please refer to Franco et al. (2023) "Pyrogenic HONO seen from space: insights from global IASI observations" (ACP, submitted), and for a description of the ANNI v4 retrievals, please consult Clarisse et al. (2023) "The IASI NH3 version 4 product: averaging kernels and improved consistency" (AMT, https://doi.org/10.5194/amt-16-5009-2023). Prior to using this dataset, we recommend reaching out to the main developers Bruno Franco (bruno.franco@ulb.be) and Lieven Clarisse (lieven.clarisse@ulb.be) for guidance and information on more recent product versions.

Compared to v1, IASI HONO product v2 contains more realistic error estimates related to the uncertainties on the fire plume altitude.
DOI: 10.5281/zenodo.10141825
title: The IASI/Metop pyrogenic HONO product

description: This dataset comprises the pyrogenic HONO product retrieved from IASI/Metop-A (Oct 2007 - Sept 2021), IASI/Metop-B (March 2013 - Sept 2023), and IASI/Metop-C (Sept 2019 - Sept 2023) using the Artificial Neural Network for IASI (ANNI) version 4 retrieval scheme. Each day with successful pyrogenic HONO detections is represented by a .nc file per instrument. For detailed information on the HONO product, please refer to Franco et al. (2023) "Pyrogenic HONO seen from space: insights from global IASI observations" (ACP, submitted), and for a description of the ANNI v4 retrievals, please consult Clarisse et al. (2023) "The IASI NH3 version 4 product: averaging kernels and improved consistency" (AMT, https://doi.org/10.5194/amt-16-5009-2023). Prior to using this dataset, we recommend reaching out to the main developers Bruno Franco (bruno.franco@ulb.be) and Lieven Clarisse (lieven.clarisse@ulb.be) for guidance and information on more recent product versions.
DOI: 10.5281/zenodo.10721381
title: The IASI/Metop pyrogenic HONO product v2

description: This dataset comprises the version 2 of the pyrogenic HONO product retrieved from IASI/Metop-A (Oct 2007 - Sept 2021), IASI/Metop-B (March 2013 - Sept 2023), and IASI/Metop-C (Sept 2019 - Sept 2023) using the Artificial Neural Network for IASI (ANNI) version 4 retrieval scheme. Each day with successful pyrogenic HONO detections is represented by a .nc file per instrument. For detailed information on the HONO product, please refer to Franco et al. (2023) "Pyrogenic HONO seen from space: insights from global IASI observations" (ACP, submitted), and for a description of the ANNI v4 retrievals, please consult Clarisse et al. (2023) "The IASI NH3 version 4 product: averaging kernels and improved consistency" (AMT, https://doi.org/10.5194/amt-16-5009-2023). Prior to using this dataset, we recommend reaching out to the main developers Bruno Franco (bruno.franco@ulb.be) and Lieven Clarisse (lieven.clarisse@ulb.be) for guidance and information on more recent product versions.

Compared to v1, IASI HONO product v2 contains more realistic error estimates related to the uncertainties on the fire plume altitude.
DOI: 10.6084/m9.figshare.8312870
title: Simultaneous variable and factor selection via sparse group lasso in factor analysis

description: This paper considers variable and factor selection in factor analysis. We treat the factor loadings for each observable variable as a group, and introduce a weighted sparse group lasso penalty to the complete log-likelihood. The proposal simultaneously selects observable variables and latent factors of a factor analysis model in a data-driven fashion; it produces a more flexible and sparse factor loading structure than existing methods. For parameter estimation, we derive an expectation-maximization algorithm that optimizes the penalized log-likelihood. The tuning parameters of the procedure are selected by a likelihood cross-validation criterion that yields satisfactory results in various simulation settings. Simulation results reveal that the proposed method can better identify the possibly sparse structure of the true factor loading matrix with higher estimation accuracy than existing methods. A real data example is also presented to demonstrate its performance in practice.
DOI: 10.6084/m9.figshare.8312870.v1
title: Simultaneous variable and factor selection via sparse group lasso in factor analysis

description: This paper considers variable and factor selection in factor analysis. We treat the factor loadings for each observable variable as a group, and introduce a weighted sparse group lasso penalty to the complete log-likelihood. The proposal simultaneously selects observable variables and latent factors of a factor analysis model in a data-driven fashion; it produces a more flexible and sparse factor loading structure than existing methods. For parameter estimation, we derive an expectation-maximization algorithm that optimizes the penalized log-likelihood. The tuning parameters of the procedure are selected by a likelihood cross-validation criterion that yields satisfactory results in various simulation settings. Simulation results reveal that the proposed method can better identify the possibly sparse structure of the true factor loading matrix with higher estimation accuracy than existing methods. A real data example is also presented to demonstrate its performance in practice.
DOI: 10.6084/m9.figshare.8312900
title: MOESM1 of Molecular and biochemical analysis of the castor caruncle reveals a set of unique genes involved in oil accumulation in non-seed tissues

description: Additional file 1: Table S1. Total soluble sugars and starch in developing seed and caruncle.
DOI: 10.6084/m9.figshare.8312900.v1
title: MOESM1 of Molecular and biochemical analysis of the castor caruncle reveals a set of unique genes involved in oil accumulation in non-seed tissues

description: Additional file 1: Table S1. Total soluble sugars and starch in developing seed and caruncle.
DOI: 10.6084/m9.figshare.8312906
title: MOESM2 of Molecular and biochemical analysis of the castor caruncle reveals a set of unique genes involved in oil accumulation in non-seed tissues

description: Additional file 2: Table S2. List of differentially expressed genes involved in fatty acid metabolism and TAG synthesis in the caruncle compared to in seed.
DOI: 10.6084/m9.figshare.8312906.v1
title: MOESM2 of Molecular and biochemical analysis of the castor caruncle reveals a set of unique genes involved in oil accumulation in non-seed tissues

description: Additional file 2: Table S2. List of differentially expressed genes involved in fatty acid metabolism and TAG synthesis in the caruncle compared to in seed.
DOI: 10.6084/m9.figshare.8312915
title: MOESM3 of Molecular and biochemical analysis of the castor caruncle reveals a set of unique genes involved in oil accumulation in non-seed tissues

description: Additional file 3: Table S3. Gene expression level comparison by RNA-seq and qRT-PCR.
DOI: 10.6084/m9.figshare.8312915.v1
title: MOESM3 of Molecular and biochemical analysis of the castor caruncle reveals a set of unique genes involved in oil accumulation in non-seed tissues

description: Additional file 3: Table S3. Gene expression level comparison by RNA-seq and qRT-PCR.
DOI: 10.6084/m9.figshare.8312918
title: MOESM4 of Molecular and biochemical analysis of the castor caruncle reveals a set of unique genes involved in oil accumulation in non-seed tissues

description: Additional file 4: Table S4. Fatty acid profile of leaf TAG with transit expression of the selected gene.
DOI: 10.6084/m9.figshare.8312918.v1
title: MOESM4 of Molecular and biochemical analysis of the castor caruncle reveals a set of unique genes involved in oil accumulation in non-seed tissues

description: Additional file 4: Table S4. Fatty acid profile of leaf TAG with transit expression of the selected gene.
DOI: 10.5281/zenodo.10719713
title: ROSMAT24: a subset of ROSMA dataset with instruments detection annotations

description: ROSMAT24 is a subset of a subset of ROSMA that includes instrument annotations for 24 videos, 22 videos of pea on a peg instances, and 2 videos of post and sleeve. Unlike most of the previous work on instrument detection, we provide separate labeled bounding boxes for the tip of PSM1 and PMS2. This data has a total of 48.919 manually annotated images.
DOI: 10.5281/zenodo.10719714
title: ROSMAT24: a subset of ROSMA dataset with instruments detection annotations

description: ROSMAT24 is a subset of a subset of ROSMA that includes instrument annotations for 24 videos, 22 videos of pea on a peg instances, and 2 videos of post and sleeve. Unlike most of the previous work on instrument detection, we provide separate labeled bounding boxes for the tip of PSM1 and PMS2. This data has a total of 48.919 manually annotated images.
DOI: 10.5281/zenodo.10721398
title: ROSMAT24: a subset of ROSMA dataset with instruments detection annotations

description: ROSMAT24 is a subset of a subset of ROSMA that includes instrument annotations for 24 videos, 22 videos of pea on a peg instances, and 2 videos of post and sleeve. Unlike most of the previous work on instrument detection, we provide separate labeled bounding boxes for the tip of PSM1 and PMS2. This data has a total of 48.919 manually annotated images.
DOI: 10.6084/m9.figshare.8312933
title: MOESM6 of Molecular and biochemical analysis of the castor caruncle reveals a set of unique genes involved in oil accumulation in non-seed tissues

description: Additional file 6: Table S5. Primers used for qRT-PCR.
DOI: 10.6084/m9.figshare.8312933.v1
title: MOESM6 of Molecular and biochemical analysis of the castor caruncle reveals a set of unique genes involved in oil accumulation in non-seed tissues

description: Additional file 6: Table S5. Primers used for qRT-PCR.
DOI: 10.6084/m9.figshare.25118024
title: Supplementary Material for: Early versus late recurrence of hepatocellular carcinoma after microwave ablation: patterns, treatments, and post-recurrence survival

description: Introduction Recurrence after microwave ablation (MWA) has not been extensively studied. We aimed to investigate the patterns, treatments, and survival of patients with hepatocellular carcinoma (HCC) who experienced early and late recurrence after MWA. 
Methods This retrospective study included patients with HCC recurrence after MWA as the initial treatment from January 2008 to December 2021. Recurrence patterns, treatments, and outcomes between patients with early and late HCC recurrence were compared. Prognostic factors of post-recurrence survival (PRS) were identified by multivariable Cox regression analyses. 
Results Among 222 patients, 128 developed early recurrence (≤2 years after MWA) and 94 had late recurrence (&gt;2 years). Majority of the recurrent HCC were intrahepatic-only recurrence, within the Milan criteria, and received potentially curative treatment. No significant differences in the recurrence patterns, vascular invasion, tumor staging, post-recurrence treatments or median PRS (35.0 vs 33.0 months, p=0.523) were identified between patients with early and late recurrence. Multivariable analyses suggested that multiple tumor number (hazard ratio (HR), 1.54; 95% CI: 1.03-2.30, p=0.038), extra-hepatic recurrence (HR, 2.14, 95% CI: 1.16-3.92, p=0.015), vascular invasion (HR, 2.37, 95% CI: 1.18-4.76, p=0.038) and higher ALBI grade (HR, 2.18, 95% CI: 1.54-3.08, p&lt;0.001) were independent risk factors of worse PRS, while curative treatment after recurrence (HR, 0.59, 95% CI: 0.38-0.92, p=0.038) was associated with better PRS.
Conclusions No differences in recurrence patterns, post-recurrent treatments or PRS were found between HCC patients with early and late recurrence following MWA. Tumor burden and patients’ liver function reserve should be considered to decide the optimal post-recurrence treatment after MWA.
DOI: 10.6084/m9.figshare.25118024.v2
title: Supplementary Material for: Early versus late recurrence of hepatocellular carcinoma after microwave ablation: patterns, treatments, and post-recurrence survival

description: Introduction Recurrence after microwave ablation (MWA) has not been extensively studied. We aimed to investigate the patterns, treatments, and survival of patients with hepatocellular carcinoma (HCC) who experienced early and late recurrence after MWA. 
Methods This retrospective study included patients with HCC recurrence after MWA as the initial treatment from January 2008 to December 2021. Recurrence patterns, treatments, and outcomes between patients with early and late HCC recurrence were compared. Prognostic factors of post-recurrence survival (PRS) were identified by multivariable Cox regression analyses. 
Results Among 222 patients, 128 developed early recurrence (≤2 years after MWA) and 94 had late recurrence (&gt;2 years). Majority of the recurrent HCC were intrahepatic-only recurrence, within the Milan criteria, and received potentially curative treatment. No significant differences in the recurrence patterns, vascular invasion, tumor staging, post-recurrence treatments or median PRS (35.0 vs 33.0 months, p=0.523) were identified between patients with early and late recurrence. Multivariable analyses suggested that multiple tumor number (hazard ratio (HR), 1.54; 95% CI: 1.03-2.30, p=0.038), extra-hepatic recurrence (HR, 2.14, 95% CI: 1.16-3.92, p=0.015), vascular invasion (HR, 2.37, 95% CI: 1.18-4.76, p=0.038) and higher ALBI grade (HR, 2.18, 95% CI: 1.54-3.08, p&lt;0.001) were independent risk factors of worse PRS, while curative treatment after recurrence (HR, 0.59, 95% CI: 0.38-0.92, p=0.038) was associated with better PRS.
Conclusions No differences in recurrence patterns, post-recurrent treatments or PRS were found between HCC patients with early and late recurrence following MWA. Tumor burden and patients’ liver function reserve should be considered to decide the optimal post-recurrence treatment after MWA.
DOI: 10.6084/m9.figshare.25118024.v1
title: Supplementary Material for: Early versus late recurrence of hepatocellular carcinoma after microwave ablation: patterns, treatments, and post-recurrence survival

description: Introduction Recurrence after microwave ablation (MWA) has not been extensively studied. We aimed to investigate the patterns, treatments, and survival of patients with hepatocellular carcinoma (HCC) who experienced early and late recurrence after MWA. 
Methods This retrospective study included patients with HCC recurrence after MWA as the initial treatment from January 2008 to December 2021. Recurrence patterns, treatments, and outcomes between patients with early and late HCC recurrence were compared. Prognostic factors of post-recurrence survival (PRS) were identified by multivariable Cox regression analyses. 
Results Among 222 patients, 128 developed early recurrence (≤2 years after MWA) and 94 had late recurrence (&gt;2 years). Majority of the recurrent HCC were intrahepatic-only recurrence, within the Milan criteria, and received potentially curative treatment. No significant differences in the recurrence patterns, vascular invasion, tumor staging, post-recurrence treatments or median PRS (35.0 vs 33.0 months, p=0.523) were identified between patients with early and late recurrence. Multivariable analyses suggested that multiple tumor number (hazard ratio (HR), 1.54; 95% CI: 1.03-2.30, p=0.038), extra-hepatic recurrence (HR, 2.14, 95% CI: 1.16-3.92, p=0.015), vascular invasion (HR, 2.37, 95% CI: 1.18-4.76, p=0.038) and higher ALBI grade (HR, 2.18, 95% CI: 1.54-3.08, p&lt;0.001) were independent risk factors of worse PRS, while curative treatment after recurrence (HR, 0.59, 95% CI: 0.38-0.92, p=0.038) was associated with better PRS.
Conclusions No differences in recurrence patterns, post-recurrent treatments or PRS were found between HCC patients with early and late recurrence following MWA. Tumor burden and patients’ liver function reserve should be considered to decide the optimal post-recurrence treatment after MWA.
DOI: 10.5281/zenodo.10721234
title: Development of an Off-Grid Solar-Powered Autonomous Chemical Mini-Plant for Producing Fine Chemicals

description: Datasets for the publication "Development of an Off-Grid Solar-Powered Autonomous Chemical Mini-Plant for Producing Fine Chemicals".
DOI: 10.5281/zenodo.10721235
title: Development of an Off-Grid Solar-Powered Autonomous Chemical Mini-Plant for Producing Fine Chemicals

description: Datasets for the publication "Development of an Off-Grid Solar-Powered Autonomous Chemical Mini-Plant for Producing Fine Chemicals".
DOI: 10.6084/m9.figshare.24565990
title: Design trends in actuated lower-limb prosthetic systems: a narrative review

description: Actuated lower limb prostheses, including powered (active) and semi-active (quasi-passive) joints, are endowed with controllable power and/or impedance, which can be advantageous to limb impairment individuals by improving locomotion mechanics and reducing the overall metabolic cost of ambulation. However, an increasing number of commercial and research-focused options have made navigating this field a daunting task for users, researchers, clinicians, and professionals. The present paper provides an overview of the latest trends and developments in the field of actuated lower-limb prostheses and corresponding technologies. Following a gentle summary of essential gait features, we introduce and compare various actuated prosthetic solutions in academia and the market designed to provide assistance at different levels of impairments. Correspondingly, we offer insights into the latest developments of sockets and suspension systems, before finally discussing the established and emerging trends in surgical approaches aimed at improving prosthetic experience through enhanced physical and neural interfaces. The ongoing challenges and future research opportunities in the field are summarized for exploring potential avenues for development of next generation of actuated lower limb prostheses. In our opinions, a closer multidisciplinary integration can be found in the field of actuated lower-limb prostheses in the future.